Kingsbury Capital Investment Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$512K Buy
2,321
+3
+0.1% +$830 0.43% 64
2026
Q1
$685K Buy
+2,318
New +$689K 0.64% 42
2022
Q3
$592K Buy
3,343
+2
+0.1% +$395 0.9% 21
2022
Q2
$684K Buy
3,341
+173
+5% +$36.7K 0.94% 22
2022
Q1
$754K Buy
+3,168
New +$744K 0.83% 25

Other funds holding CME

Kingsbury Capital Investment Advisors's CME Position: Q2 2026 in Review

Kingsbury Capital Investment Advisors increased its CME Group (CME) stake by 0.13% in Q2 2026, buying an estimated $830 and bringing the position to 2,321 shares worth $512K. The position accounts for 0.43% of the portfolio, ranked #64.

Kingsbury Capital Investment Advisors first reported a position in CME in Q1 2022 and has held it in 5 quarters since. The position peaked at $754K in Q1 2022. 1,709 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Kingsbury Capital Investment Advisors held 2,321 shares of CME Group worth $512K as of Q2 2026.
  • Kingsbury Capital Investment Advisors bought 3 CME Group shares in Q2 2026, an estimated $830.
  • CME Group made up 0.43% of Kingsbury Capital Investment Advisors's portfolio in Q2 2026, its #64 holding.
  • Kingsbury Capital Investment Advisors first reported a position in CME Group in Q1 2022 and has held it in 5 quarters since.
  • Kingsbury Capital Investment Advisors's CME Group position peaked at $754K in Q1 2022.
  • 1,709 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Kingsbury Capital Investment Advisors's 13F filing for Q2 2026, filed 25 Aug 2026.